Cargando…
MicroRNA-30a increases the chemosensitivity of U251 glioblastoma cells to temozolomide by directly targeting beclin 1 and inhibiting autophagy
Temozolomide (TMZ) is one of the most commonly used drugs for the clinical treatment of glioblastomas. However, it has been reported that treatment with TMZ can induce autophagy, which leads to tumor resistance and increases the survival of tumor cells. MicroRNA-30a (miR-30a) has been found to have...
Autores principales: | Xu, Jing, Huang, He, Peng, Renjun, Ding, Xiping, Jiang, Bing, Yuan, Xianrui, Xi, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952084/ https://www.ncbi.nlm.nih.gov/pubmed/29805498 http://dx.doi.org/10.3892/etm.2018.6007 |
Ejemplares similares
-
Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma
por: Zhao, Zijin, et al.
Publicado: (2021) -
MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT
por: Zhao, Chengbin, et al.
Publicado: (2020) -
MicroRNA‐30a ameliorates hepatic fibrosis by inhibiting Beclin1‐mediated autophagy
por: Chen, Jianliang, et al.
Publicado: (2017) -
Effect of Corilagin on the Proliferation and NF-κB in U251 Glioblastoma Cells and U251 Glioblastoma Stem-Like Cells
por: Yang, Wen-Tao, et al.
Publicado: (2016) -
Effect of temozolomide on livin and caspase-3 in U251 glioma stem cells
por: LI, GENHUA, et al.
Publicado: (2015)